课题基金 / 基金详情

Diabetic cardiomyopathy - new molecular intervention targets and a biomarker strategy

Diabetic cardiomyopathy - new molecular intervention targets and a biomarker strategy
糖尿病心肌病——新的分子干预靶点和生物标志物策略
批准号:
nhmrc : GNT1157320
负责人:
金额:
$102.0万
依托单位:
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2019
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2019-01-01 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diabetes is an epidemic disease. The major cause of death is due to heart damage and no cardiac specific therapies are available. In this project we investigate the role of glucose-related damage to the proteins which are key in regulating effective heart contraction and pump action and pursue new opportunities to measure these proteins as a blood biomarker of disease. The aim is to advance understanding of disease mechanisms and develop a strategy to diagnose cardiac glucose damage in diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
MicroRNA-195在糖尿病性心肌病发生中的作用及其机理的探讨
  • 批准号:
    81170204
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2011
  • 负责人:
    李剑敏
  • 依托单位: